Affinor Growers (CSE:AFI) announces $2 million private placement

Source: Affinor Growers Inc.

Affinor Growers Inc. (CSE.AFIOTCQB: RSSFFForum) is undertaking a private placement for gross proceeds of up to $2,000,000. The company will issue up to 10,000,000 units at a price of $0.20 per unit. Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to acquire one additional share at a price of $0.30 for a period of 24 months.

Read the Full Story Here

Weekly Update – Top Cannabis News Stories

1 | Top Story: Psyched Wellness Corp. (CSE:PSYC) to remain ‘CALM’ during first pilot production run.

2 | Pure Extracts Technologies Corp. (CSE:PULL) signs supplier agreement with Shoppers Drug Mart

3 | Tilray Brands Inc. (TSX:TLRY) expands medical cannabis products in the United Kingdom.

4 | Red Light Holland Corp. (CSE:TRIP) updates plan to enter Oregon’s psilocybin market.

5 | Aleafia Health Inc. (TSX:AH) closes $5.6 million private placement.

Top Cannabis Stocks June 23 to June 29, 2022

1. TSX:WEED | 12,446 views | Canopy Growth Stock.
2. TSX:HEXO |8,637 views | HEXO Corp.
3. NASDAQ:TLRY | 6,826 views | Tilray Brands Inc.
4. CSE:TNY | 5,808 views | Tinley Beverage Co Inc.
5. TSX:AH | 4,175 views | Aleafia Health Inc.
6. TSXV:LFST | 2,479 views | Lifeist Wellness Inc.


New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.


For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.